Federal Register / Vol. 63, No. 78 /Thursday, April 23, 1998 / Notices 20207

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings:

Name of SEP: Targeted HIV Vaccine and

other Biomedical Prevention Research and

Development.

Date: April 29, 1998.

Time: 1:00 p.m. to Adjournment.

Place: Teleconference, Solar Building,

Room 4C07, 6003 Executive Boulevard,

Rockville, MD 20892, (301) 496–2550.

Contact Person: Dr. Dianne E. Tingley,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C07,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate contract

proposals.

Name of SEP: Immunology Quality

Assessment Program.

Date: May 1, 1998.

Time: 1:00 p.m. to Adjournment.

Place: Sheraton Crystal City HotelArlington, 1800 Jefferson Davis Highway,

Arlington, VA 22202, (703) 486–1111.

Contact Person: Dr. Edward Schroder,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C38,

Bethesda, MD 20892, (301) 435–8537.

Purpose/Agenda: To evaluate contract

proposals.

Name of SEP: SPIRAT Supplement.

Date: May 5, 1998.

Time: 11:00 a.m. to Adjournment.

Place: Teleconference, Solar Building,

Room 4C05, 6003 Executive Boulevard,

Bethesda, MD 20892, (301) 496–7966.

Contact Person: Dr. Allen C. Stoolmiller,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C05,

Bethesda, MD 20892, (301) 496–7966.

Purpose/Agenda: To evaluate a grant

application.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: April 16, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10876 Filed 4–22–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

SEP: Mechanisms of Ige Regulation on

Human Leukocytes.

Date: May 8, 1998.

Time: 12:30 p.m. to Adjournment.

Place: Teleconference, Solar Building,

Room 1A2, 6003 Executive Blvd., Bethesda,

MD 20892, (301) 496–2550.

Contact Person: Dr. Vassil Georgiev,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C04,

Bethesda, Maryland 20892, (301) 496–8206.

Purpose/Agenda: To evaluate a grant

application.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: April 16, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–10877 Filed 4–22–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARMTENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Meeting: AIDS Research Advisory

Committee, National Institute of

Allergy and Infectious Diseases

Pursuant to Pub. L. 92–463; notice is

hereby given of the meeting of the AIDS

Research Advisory Committee, National

Institute of Allergy and Infectious

Diseases, on June 2, 1998 in Conference

Rooms E1 and E2, Natcher Conference

Center, Building 45, at the National

Institutes of Health, 9000 Rockville

Pike, Bethesda, Maryland.

The entire meeting will be open to the

public from 8:30 a.m. until

adjournment. The AIDS Research

Advisory Committee (ARAC) advises

and makes recommendations to the

Director, National Institute of Allergy

and Infectious Diseases, on all aspects of

research on HIV and AIDS related to the

mission of the Division of AIDS

(DAIDS).

The Committee will provide advice

on scientific priorities, policy, and

program balance at the Division level.

The Committee will review the progress

and productivity of ongoing efforts, and

identify critical gaps/obstacles to

progress. Attendance by the public will

be limited to space available.

Ms. Rona L. Siskind, Executive

Secretary, AIDS Research Advisory

Committee, DAIDS, NIAID, NIH, Solar

Building, Room 2A21, telephone 301–

435–3732, will provide a summary of

the meeting and a roster of committee

members upon request. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Siskind in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: April 16, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 98–10878 Filed 4–22–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Child Health and

Human Development Special Emphasis

Panel (SEP) meetings:

Name of SEP: Prenatal Childhood

Exposures and Age at Menarche

(Teleconference).

Date: April 26, 1998.

Time: 4:00 p.m.—adjournment.